Static Chart Perspective Therapeutics, Inc.

Stocks

Delayed NYSE Other stock markets 04:00:00 03/07/2026 HKT			5-day change	1st Jan Change
3.630 ^USD	+4.91%		+21.00%	+32.00%

06-03	Perspective Therapeutics Doses First Meningioma Patient in Phase 1/2a Study Cohort	MT
06-03	Perspective Therapeutics Doses First Patient with [212Pb]Vmt-?-Net in Meningioma Cohort of Phase 1/2A Study	CI

Duration

Period